Inozyme Short Long Term Debt Total from 2010 to 2024

INZY Stock  USD 4.67  0.04  0.86%   
Inozyme PharmaInc Short and Long Term Debt Total yearly trend continues to be fairly stable with very little volatility. Short and Long Term Debt Total is likely to outpace its year average in 2024. During the period from 2010 to 2024, Inozyme PharmaInc Short and Long Term Debt Total regression line of annual values had r-squared of  0.40 and arithmetic mean of  7,987,973. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2010-12-31
Previous Quarter
46.6 M
Current Value
48.9 M
Quarterly Volatility
16.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inozyme PharmaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inozyme main balance sheet or income statement drivers, such as Net Interest Income of 4.3 M, Interest Income of 4.3 M or Depreciation And Amortization of 1.4 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.65. Inozyme financial statements analysis is a perfect complement when working with Inozyme PharmaInc Valuation or Volatility modules.
  
This module can also supplement Inozyme PharmaInc's financial leverage analysis and stock options assessment as well as various Inozyme PharmaInc Technical models . Check out the analysis of Inozyme PharmaInc Correlation against competitors.
For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme PharmaInc guide.

Latest Inozyme PharmaInc's Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Inozyme PharmaInc over the last few years. It is Inozyme PharmaInc's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inozyme PharmaInc's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Inozyme Short Long Term Debt Total Regression Statistics

Arithmetic Mean7,987,973
Geometric Mean2,482,004
Coefficient Of Variation203.04
Mean Deviation10,605,020
Median1,287,000
Standard Deviation16,218,478
Sample Variance263T
Range47.6M
R-Value0.63
Mean Square Error170.4T
R-Squared0.40
Significance0.01
Slope2,289,511
Total Sum of Squares3682.5T

Inozyme Short Long Term Debt Total History

202448.9 M
202346.6 M
20226.8 M
20213.4 M

About Inozyme PharmaInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Inozyme PharmaInc income statement, its balance sheet, and the statement of cash flows. Inozyme PharmaInc investors use historical funamental indicators, such as Inozyme PharmaInc's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Inozyme PharmaInc investors may use each financial statement separately, they are all related. The changes in Inozyme PharmaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inozyme PharmaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Inozyme PharmaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Inozyme PharmaInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total46.6 M48.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Inozyme PharmaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inozyme PharmaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inozyme Pharmainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inozyme Pharmainc Stock:
Check out the analysis of Inozyme PharmaInc Correlation against competitors.
For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme PharmaInc guide.
Note that the Inozyme PharmaInc information on this page should be used as a complementary analysis to other Inozyme PharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Inozyme Stock analysis

When running Inozyme PharmaInc's price analysis, check to measure Inozyme PharmaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme PharmaInc is operating at the current time. Most of Inozyme PharmaInc's value examination focuses on studying past and present price action to predict the probability of Inozyme PharmaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme PharmaInc's price. Additionally, you may evaluate how the addition of Inozyme PharmaInc to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Inozyme PharmaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inozyme PharmaInc. If investors know Inozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inozyme PharmaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.35)
Return On Assets
(0.33)
Return On Equity
(0.69)
The market value of Inozyme PharmaInc is measured differently than its book value, which is the value of Inozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Inozyme PharmaInc's value that differs from its market value or its book value, called intrinsic value, which is Inozyme PharmaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inozyme PharmaInc's market value can be influenced by many factors that don't directly affect Inozyme PharmaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inozyme PharmaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inozyme PharmaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inozyme PharmaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.